- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 115.97M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 114.18M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 92.65M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $632K |
| Capex | Q1 2026 · Mar 31, 2025 | $34K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$8.06M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$7.62M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $157.5M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $172.65M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $1.52M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $30.17M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $37.8M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $23.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $33.49M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $18.38M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $59.69M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $63.79M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $251.7M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $274.21M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $59.46M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $65.47M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $285.78M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $292.37M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $23.23M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $25.4M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.64M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$6.26M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $20.69M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $19.82M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $9.54M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $9.05M |
| Revenue | Q1 2026 · Mar 31, 2026 | $30.24M |
| Revenue | Q1 2026 · Mar 31, 2025 | $28.88M |